These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 8632410

  • 1. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L.
    J Med Chem; 1996 Feb 16; 39(4):860-72. PubMed ID: 8632410
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M, Canullo L, Braile C, Cappelli A, Gallelli A, Vomero S, Menziani MC, De Benedetti PG, Rizzo M, Collina S, Azzolina O, Sbacchi M, Ghelardini C, Galeotti N.
    J Med Chem; 2003 Aug 28; 46(18):3853-64. PubMed ID: 12930147
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 4. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R.
    J Med Chem; 1997 Feb 28; 40(5):695-704. PubMed ID: 9057856
    [Abstract] [Full Text] [Related]

  • 5. Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DF, Freidinger RM, Chang RS, Chen TB, Lotti VJ.
    J Med Chem; 1990 Jan 28; 33(1):450-5. PubMed ID: 2153212
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y, Zhang X, Homma K, Rice KC, Calderon SN, Rothman RB, Yamamura HI, Davis P, Flippen-Anderson JL, Xu H, Becketts K, Foltz EJ, Porreca F.
    J Med Chem; 1997 Aug 29; 40(18):2936-47. PubMed ID: 9288176
    [Abstract] [Full Text] [Related]

  • 9. Opioid receptor selectivity of peptide models of beta-endorphin.
    Taylor JW, Kaiser ET.
    Int J Pept Protein Res; 1989 Jul 29; 34(1):75-80. PubMed ID: 2551833
    [Abstract] [Full Text] [Related]

  • 10. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF, Xu H, Liu-Chen LY, Chen C, Partilla JS, Brine GA, Carroll FI, Rice KC, Lai J, Porreca F, Sadee W, Rothman RB.
    Synapse; 1998 Feb 29; 28(2):117-24. PubMed ID: 9450512
    [Abstract] [Full Text] [Related]

  • 11. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR.
    Biopolymers; 1995 Oct 29; 36(4):439-52. PubMed ID: 7578939
    [Abstract] [Full Text] [Related]

  • 12. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
    Zhang A, Xiong W, Bidlack JM, Hilbert JE, Knapp BI, Wentland MP, Neumeyer JL.
    J Med Chem; 2004 Jan 01; 47(1):165-74. PubMed ID: 14695830
    [Abstract] [Full Text] [Related]

  • 13. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
    Bennett MA, Murray TF, Aldrich JV.
    J Pept Res; 2005 Mar 28; 65(3):322-32. PubMed ID: 15787962
    [Abstract] [Full Text] [Related]

  • 15. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 16. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
    Szatmári I, Orosz G, Medzihradszky K, Borsodi A.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):513-9. PubMed ID: 10558900
    [Abstract] [Full Text] [Related]

  • 17. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 1999 Nov 19; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 18. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM, Traynor JR.
    Can J Physiol Pharmacol; 1998 Mar 19; 76(3):325-33. PubMed ID: 9673796
    [Abstract] [Full Text] [Related]

  • 19. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec 19; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 20. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M.
    Mol Pharmacol; 1996 Nov 19; 50(5):1413-22. PubMed ID: 8913373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.